Kit for quantitatively detecting heart-type fatty acid binding protein, and preparation method thereof
A fatty acid combination and quantitative detection technology, applied in the field of biomedicine, can solve the problems of poor specificity and low sensitivity, and achieve the effect of high specificity, high sensitivity, and guaranteed sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Example 1 Preparation of H-FABP Acridine Lipid Labeled Monoclonal Antibody
[0054] 1) Weigh an appropriate amount of H-FABP monoclonal antibody, and use 0.05mol / L pH 9.5 CB to adjust to 1mg / mL;
[0055] 2) Acridine lipid and antibody are calculated according to 1:15 mole ratio, dissolved in DMF, mixed, and reacted at room temperature for 30 minutes;
[0056] 3) The reaction solution was transferred to a dialysis bag (molecular weight cut-off 8000-12000), and dialyzed with 0.01M PBS with pH 7.2 for 24 hours;
[0057] 4) Add an equal volume of glycerin and 0.1% PC-300 by volume.
Embodiment 2
[0058] Example 2 Preparation of the H-FABP quantitative assay kit of the present invention
[0059] 1. Preparation of acridine lipid antibody
[0060] 1. Acridine-labeled monoclonal antibody diluent Buffer A:
[0061] Buffer A: 0.01-0.1M PBS pH 7.2, 0.1%-1%BSA, 0.2% PC-300
[0062] 2. Select the concentration of acridine-labeled monoclonal antibody:
[0063] The working concentration of acridinium-labeled monoclonal antibody is greater than 0.41μg / mL.
[0064] 2. Preparation of H-FABP calibrator
[0065] Dilute the H-FABP antigen with 0.01M PBS pH 7.2, 0.5% bovine serum albumin (BSA) diluent, and prepare five kinds of calibrator with standard concentration of 1, 5, 25, 100, 500ng / mL.
[0066] 3. Preparation of acridine-labeled antibody:
[0067] 1) Weigh an appropriate amount of H-FABP monoclonal antibody, and use 0.05mol / L pH 9.5 CB to adjust to 1mg / mL;
[0068] 2) Acridine lipid and antibody are calculated according to 1:15 moles, dissolved in DMF, mixed, and reacted a...
Embodiment 3
[0094] Example 3 Buffer Buffer
[0095] The buffer is an important component of the present invention, which is a buffer for diluting biotinylated antibodies, antibodies labeled with acridine derivatives, and magnetic particles coupled with anti-biotin antibodies, using a combination of BSA, trehalose, and casein The formula improves the non-specific physical adsorption of immunoglobulin by magnetic particles, adding sheep immunoglobulin G (sheep IgG) and mouse IgG to further reduce the specific binding, reduce the HAMA effect, and improve the analytical sensitivity of the reagent.
[0096] Buffer A: 0.01-0.1M PBS pH 7.2, mass ratio 0.1%-1%BSA, volume ratio 0.2% PC-300;
[0097] Buffer B: use 0.01-0.1M 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), 150mM NaCl, mass ratio 0.1%-1%BSA, mass ratio 0.1%-5% trehalose, mass ratio 0.5%-1 % casein sodium salt, rabbit IgG 5mg / mL, sheep IgG 3mg / mL, mouse IgG 1 mg / mL, volume ratio 0.2% PC-300, pH 7.2.
[0098] In one embodiment, t...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com